Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
81 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
7% more funds holding
Funds holding: 76 → 81 (+5)
0% less capital invested
Capital invested by funds: $135M → $135M (-$360K)
15% less call options, than puts
Call options by funds: $3.26M | Put options by funds: $3.85M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$383K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$338K |
| 3 |
Goldman Sachs
New York
|
+$241K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$240K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$236K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.65M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$668K |
| 3 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$548K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$365K |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
-$148K |
IMMU Hedge Fund Activity: Q3 2014 in Review
81 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2014, worth a combined $135M — down 0.27% from $135M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.
The largest buyer was Vanguard Group, adding an estimated $383K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.65M sold.
- 81 institutional investors held Immunomedics Inc (IMMU) as of Q3 2014, up from 76 in Q2 2014.
- Funds reported $135M of Immunomedics Inc stock for Q3 2014, down 0.27% quarter-over-quarter.
- 12 funds opened new Immunomedics Inc positions in Q3 2014 and 7 closed out, a net change of +5 holders.
- The largest Immunomedics Inc buyer in Q3 2014 was Vanguard Group, an estimated $383K added.
- The largest Immunomedics Inc seller in Q3 2014 was RA Capital Management, an estimated $3.65M sold.
Based on aggregated 13F filings for Q3 2014.